Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Identifieur interne : 000441 ( Main/Corpus ); précédent : 000440; suivant : 000442Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Auteurs : Maziar Emamikhah ; Mansoureh Babadi ; Mehrnoush Mehrabani ; Mehdi Jalili ; Maryam Pouranian ; Peyman Daraie ; Fahimeh Mohaghegh ; Sharmin Aghavali ; Maryam Zaribafian ; Mohammad RohaniSource :
- Journal of neurovirology [ 1538-2443 ] ; 2021.
English descriptors
- KwdEn :
- Adult (MeSH), Anticonvulsants (therapeutic use), Ataxia (diagnostic imaging), Ataxia (drug therapy), Ataxia (etiology), Ataxia (physiopathology), Azithromycin (therapeutic use), COVID-19 (complications), COVID-19 (diagnostic imaging), COVID-19 (drug therapy), COVID-19 (physiopathology), Clonazepam (therapeutic use), Cough (diagnostic imaging), Cough (drug therapy), Cough (etiology), Cough (physiopathology), Dyspnea (diagnostic imaging), Dyspnea (drug therapy), Dyspnea (etiology), Dyspnea (physiopathology), Female (MeSH), Fever (diagnostic imaging), Fever (drug therapy), Fever (etiology), Fever (physiopathology), Humans (MeSH), Hydroxychloroquine (therapeutic use), Levetiracetam (therapeutic use), Male (MeSH), Middle Aged (MeSH), Myalgia (diagnostic imaging), Myalgia (drug therapy), Myalgia (etiology), Myalgia (physiopathology), Opsoclonus-Myoclonus Syndrome (diagnostic imaging), Opsoclonus-Myoclonus Syndrome (drug therapy), Opsoclonus-Myoclonus Syndrome (etiology), Opsoclonus-Myoclonus Syndrome (physiopathology), Oseltamivir (therapeutic use), SARS-CoV-2 (drug effects), SARS-CoV-2 (pathogenicity), Valproic Acid (therapeutic use).
- MESH :
- chemical , therapeutic use : Anticonvulsants, Azithromycin, Clonazepam, Hydroxychloroquine, Levetiracetam, Oseltamivir, Valproic Acid.
- complications : COVID-19.
- diagnostic imaging : Ataxia, COVID-19, Cough, Dyspnea, Fever, Myalgia, Opsoclonus-Myoclonus Syndrome.
- drug effects : SARS-CoV-2.
- drug therapy : Ataxia, COVID-19, Cough, Dyspnea, Fever, Myalgia, Opsoclonus-Myoclonus Syndrome.
- etiology : Ataxia, Cough, Dyspnea, Fever, Myalgia, Opsoclonus-Myoclonus Syndrome.
- pathogenicity : SARS-CoV-2.
- physiopathology : Ataxia, COVID-19, Cough, Dyspnea, Fever, Myalgia, Opsoclonus-Myoclonus Syndrome.
- Adult, Female, Humans, Male, Middle Aged.
Abstract
Opsoclonus-myoclonus-ataxia syndrome is a heterogeneous constellation of symptoms ranging from full combination of these three neurological findings to varying degrees of isolated individual sign. Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered. As a neuro-inflammatory disorder, one would expect to observe opsoclonus-myoclonus syndrome after a prevalent viral infection in a pandemic scale, as it has been the case for many other neuro-inflammatory syndromes. We report seven cases of opsoclonus-myoclonus syndrome presumably parainfectious in nature and discuss their phenomenology, their possible pathophysiological relationship to COVID-19, and diagnostic and treatment strategy in each case. Finally, we review the relevant data in the literature regarding the opsoclonus-myoclonus syndrome and possible similar cases associated with COVID-19 and its diagnostic importance for clinicians in various fields of medicine encountering COVID-19 patients and its complications.
DOI: 10.1007/s13365-020-00941-1
PubMed: 33492608
PubMed Central: PMC7831695
Links to Exploration step
pubmed:33492608Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.</title><author><name sortKey="Emamikhah, Maziar" sort="Emamikhah, Maziar" uniqKey="Emamikhah M" first="Maziar" last="Emamikhah">Maziar Emamikhah</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Babadi, Mansoureh" sort="Babadi, Mansoureh" uniqKey="Babadi M" first="Mansoureh" last="Babadi">Mansoureh Babadi</name><affiliation><nlm:affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mehrabani, Mehrnoush" sort="Mehrabani, Mehrnoush" uniqKey="Mehrabani M" first="Mehrnoush" last="Mehrabani">Mehrnoush Mehrabani</name><affiliation><nlm:affiliation>Fajr Hospital, AJA University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Jalili, Mehdi" sort="Jalili, Mehdi" uniqKey="Jalili M" first="Mehdi" last="Jalili">Mehdi Jalili</name><affiliation><nlm:affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Pouranian, Maryam" sort="Pouranian, Maryam" uniqKey="Pouranian M" first="Maryam" last="Pouranian">Maryam Pouranian</name><affiliation><nlm:affiliation>Amiralmomenin Hospital, Zabol University of Medical Sciences, Zabol, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Daraie, Peyman" sort="Daraie, Peyman" uniqKey="Daraie P" first="Peyman" last="Daraie">Peyman Daraie</name><affiliation><nlm:affiliation>Khatamolanbia Hospital, Shoushtar University of Medical Sciences, Khuzestan Province, Shoushtar, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mohaghegh, Fahimeh" sort="Mohaghegh, Fahimeh" uniqKey="Mohaghegh F" first="Fahimeh" last="Mohaghegh">Fahimeh Mohaghegh</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Aghavali, Sharmin" sort="Aghavali, Sharmin" uniqKey="Aghavali S" first="Sharmin" last="Aghavali">Sharmin Aghavali</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Zaribafian, Maryam" sort="Zaribafian, Maryam" uniqKey="Zaribafian M" first="Maryam" last="Zaribafian">Maryam Zaribafian</name><affiliation><nlm:affiliation>Nikan Hospital, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Rohani, Mohammad" sort="Rohani, Mohammad" uniqKey="Rohani M" first="Mohammad" last="Rohani">Mohammad Rohani</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Skull Base Research Center , Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:33492608</idno><idno type="pmid">33492608</idno><idno type="doi">10.1007/s13365-020-00941-1</idno><idno type="pmc">PMC7831695</idno><idno type="wicri:Area/Main/Corpus">000441</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000441</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.</title><author><name sortKey="Emamikhah, Maziar" sort="Emamikhah, Maziar" uniqKey="Emamikhah M" first="Maziar" last="Emamikhah">Maziar Emamikhah</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Babadi, Mansoureh" sort="Babadi, Mansoureh" uniqKey="Babadi M" first="Mansoureh" last="Babadi">Mansoureh Babadi</name><affiliation><nlm:affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mehrabani, Mehrnoush" sort="Mehrabani, Mehrnoush" uniqKey="Mehrabani M" first="Mehrnoush" last="Mehrabani">Mehrnoush Mehrabani</name><affiliation><nlm:affiliation>Fajr Hospital, AJA University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Jalili, Mehdi" sort="Jalili, Mehdi" uniqKey="Jalili M" first="Mehdi" last="Jalili">Mehdi Jalili</name><affiliation><nlm:affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Pouranian, Maryam" sort="Pouranian, Maryam" uniqKey="Pouranian M" first="Maryam" last="Pouranian">Maryam Pouranian</name><affiliation><nlm:affiliation>Amiralmomenin Hospital, Zabol University of Medical Sciences, Zabol, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Daraie, Peyman" sort="Daraie, Peyman" uniqKey="Daraie P" first="Peyman" last="Daraie">Peyman Daraie</name><affiliation><nlm:affiliation>Khatamolanbia Hospital, Shoushtar University of Medical Sciences, Khuzestan Province, Shoushtar, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mohaghegh, Fahimeh" sort="Mohaghegh, Fahimeh" uniqKey="Mohaghegh F" first="Fahimeh" last="Mohaghegh">Fahimeh Mohaghegh</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Aghavali, Sharmin" sort="Aghavali, Sharmin" uniqKey="Aghavali S" first="Sharmin" last="Aghavali">Sharmin Aghavali</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Zaribafian, Maryam" sort="Zaribafian, Maryam" uniqKey="Zaribafian M" first="Maryam" last="Zaribafian">Maryam Zaribafian</name><affiliation><nlm:affiliation>Nikan Hospital, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Rohani, Mohammad" sort="Rohani, Mohammad" uniqKey="Rohani M" first="Mohammad" last="Rohani">Mohammad Rohani</name><affiliation><nlm:affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Skull Base Research Center , Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of neurovirology</title><idno type="eISSN">1538-2443</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Anticonvulsants (therapeutic use)</term><term>Ataxia (diagnostic imaging)</term><term>Ataxia (drug therapy)</term><term>Ataxia (etiology)</term><term>Ataxia (physiopathology)</term><term>Azithromycin (therapeutic use)</term><term>COVID-19 (complications)</term><term>COVID-19 (diagnostic imaging)</term><term>COVID-19 (drug therapy)</term><term>COVID-19 (physiopathology)</term><term>Clonazepam (therapeutic use)</term><term>Cough (diagnostic imaging)</term><term>Cough (drug therapy)</term><term>Cough (etiology)</term><term>Cough (physiopathology)</term><term>Dyspnea (diagnostic imaging)</term><term>Dyspnea (drug therapy)</term><term>Dyspnea (etiology)</term><term>Dyspnea (physiopathology)</term><term>Female (MeSH)</term><term>Fever (diagnostic imaging)</term><term>Fever (drug therapy)</term><term>Fever (etiology)</term><term>Fever (physiopathology)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Levetiracetam (therapeutic use)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Myalgia (diagnostic imaging)</term><term>Myalgia (drug therapy)</term><term>Myalgia (etiology)</term><term>Myalgia (physiopathology)</term><term>Opsoclonus-Myoclonus Syndrome (diagnostic imaging)</term><term>Opsoclonus-Myoclonus Syndrome (drug therapy)</term><term>Opsoclonus-Myoclonus Syndrome (etiology)</term><term>Opsoclonus-Myoclonus Syndrome (physiopathology)</term><term>Oseltamivir (therapeutic use)</term><term>SARS-CoV-2 (drug effects)</term><term>SARS-CoV-2 (pathogenicity)</term><term>Valproic Acid (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term><term>Azithromycin</term><term>Clonazepam</term><term>Hydroxychloroquine</term><term>Levetiracetam</term><term>Oseltamivir</term><term>Valproic Acid</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>COVID-19</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Ataxia</term><term>COVID-19</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>Myalgia</term><term>Opsoclonus-Myoclonus Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Ataxia</term><term>COVID-19</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>Myalgia</term><term>Opsoclonus-Myoclonus Syndrome</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Ataxia</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>Myalgia</term><term>Opsoclonus-Myoclonus Syndrome</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Ataxia</term><term>COVID-19</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>Myalgia</term><term>Opsoclonus-Myoclonus Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Opsoclonus-myoclonus-ataxia syndrome is a heterogeneous constellation of symptoms ranging from full combination of these three neurological findings to varying degrees of isolated individual sign. Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered. As a neuro-inflammatory disorder, one would expect to observe opsoclonus-myoclonus syndrome after a prevalent viral infection in a pandemic scale, as it has been the case for many other neuro-inflammatory syndromes. We report seven cases of opsoclonus-myoclonus syndrome presumably parainfectious in nature and discuss their phenomenology, their possible pathophysiological relationship to COVID-19, and diagnostic and treatment strategy in each case. Finally, we review the relevant data in the literature regarding the opsoclonus-myoclonus syndrome and possible similar cases associated with COVID-19 and its diagnostic importance for clinicians in various fields of medicine encountering COVID-19 patients and its complications.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33492608</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2443</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>02</Month></PubDate></JournalIssue><Title>Journal of neurovirology</Title><ISOAbbreviation>J Neurovirol</ISOAbbreviation></Journal><ArticleTitle>Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.</ArticleTitle><Pagination><MedlinePgn>26-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13365-020-00941-1</ELocationID><Abstract><AbstractText>Opsoclonus-myoclonus-ataxia syndrome is a heterogeneous constellation of symptoms ranging from full combination of these three neurological findings to varying degrees of isolated individual sign. Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered. As a neuro-inflammatory disorder, one would expect to observe opsoclonus-myoclonus syndrome after a prevalent viral infection in a pandemic scale, as it has been the case for many other neuro-inflammatory syndromes. We report seven cases of opsoclonus-myoclonus syndrome presumably parainfectious in nature and discuss their phenomenology, their possible pathophysiological relationship to COVID-19, and diagnostic and treatment strategy in each case. Finally, we review the relevant data in the literature regarding the opsoclonus-myoclonus syndrome and possible similar cases associated with COVID-19 and its diagnostic importance for clinicians in various fields of medicine encountering COVID-19 patients and its complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emamikhah</LastName><ForeName>Maziar</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8375-5262</Identifier><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babadi</LastName><ForeName>Mansoureh</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8907-1168</Identifier><AffiliationInfo><Affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabani</LastName><ForeName>Mehrnoush</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fajr Hospital, AJA University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalili</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ganjavian Hospital, Dezful University of Medical Sciences, Khuzestan Province, Dezful, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouranian</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3170-8442</Identifier><AffiliationInfo><Affiliation>Amiralmomenin Hospital, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daraie</LastName><ForeName>Peyman</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Khatamolanbia Hospital, Shoushtar University of Medical Sciences, Khuzestan Province, Shoushtar, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohaghegh</LastName><ForeName>Fahimeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aghavali</LastName><ForeName>Sharmin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaribafian</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nikan Hospital, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohani</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5409-1804</Identifier><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Hazrat Rasool-E Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Skull Base Research Center , Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurovirol</MedlineTA><NlmUniqueID>9508123</NlmUniqueID><ISSNLinking>1355-0284</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical><Chemical><RegistryNumber>44YRR34555</RegistryNumber><NameOfSubstance UI="D000077287">Levetiracetam</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5PE9FDE8GB</RegistryNumber><NameOfSubstance UI="D002998">Clonazepam</NameOfSubstance></Chemical><Chemical><RegistryNumber>614OI1Z5WI</RegistryNumber><NameOfSubstance UI="D014635">Valproic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002998" MajorTopicYN="N">Clonazepam</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077287" MajorTopicYN="N">Levetiracetam</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053578" MajorTopicYN="N">Opsoclonus-Myoclonus Syndrome</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014635" MajorTopicYN="N">Valproic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Myoclonus</Keyword><Keyword MajorTopicYN="Y">Opsoclonus</Keyword><Keyword MajorTopicYN="Y">Parainfectious</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>25</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33492608</ArticleId><ArticleId IdType="doi">10.1007/s13365-020-00941-1</ArticleId><ArticleId IdType="pii">10.1007/s13365-020-00941-1</ArticleId><ArticleId IdType="pmc">PMC7831695</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beach SR, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N, Fricchione GL, Smith FA (2020) Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. https://doi.org/10.1016/j.genhosppsych.2020.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2020.05.008</ArticleId><ArticleId IdType="pubmed">32979582</ArticleId><ArticleId IdType="pmcid">7242189</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron L, Kilbane C (2019) Opsoclonus Myoclonus Syndrome. In: Advances in Translational Neuroscience of Eye Movement Disorders. Springer, pp 471-486. https://doi.org/10.1007/978-3-030-31407-1_23</Citation></Reference><Reference><Citation>Caviness JN (2019) Myoclonus CONTINUUM: Lifelong Learning in Neurology 25:1055–1080. https://doi.org/10.1212/CON.0000000000000750</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000750</ArticleId><ArticleId IdType="pubmed">31356293</ArticleId></ArticleIdList></Reference><Reference><Citation>Caviness JN, Brown P (2004) Myoclonus: current concepts and recent advances. Lancet Neurol 3:598–607. https://doi.org/10.1016/S1474-4422(04)00880-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(04)00880-4</ArticleId><ArticleId IdType="pubmed">15380156</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumont H, San-Galli A, Martino F, Couratier C, Joguet G, Carles M, Roze E, Lannuzel A (2020) Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. J Neurol 1–7. https://doi.org/10.1007/s00415-020-09986-y</Citation></Reference><Reference><Citation>Cranshaw T, Harikumar T (2020) COVID-19 infection may cause clozapine intoxication: case report and discussion. Schizophr Bull. https://doi.org/10.1093/schbul/sbaa070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa070</ArticleId><ArticleId IdType="pubmed">32435811</ArticleId><ArticleId IdType="pmcid">7313764</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkstra F, Van den Bossche T, Willekens B, Cras P, Crosiers D (2020) Myoclonus and cerebellar ataxia following Coronavirus Disease 2019 (COVID-19). Mov Disord Clin Pract. https://doi.org/10.1002/mdc3.13049</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13049</ArticleId><ArticleId IdType="pubmed">32837962</ArticleId><ArticleId IdType="pmcid">7436437</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson J, Kumar R, McEvoy KF, McKeon A (2012) Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol 69:1598–1607. https://doi.org/10.1001/archneurol.2012.1173</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2012.1173</ArticleId><ArticleId IdType="pubmed">22986354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojovic M, Cordivari C, Bhatia K (2011) Myoclonic disorders: a practical approach for diagnosis and treatment. Therapeutic Adv Neurol Disord 4:47–62. https://doi.org/10.1177/1756285610395653</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285610395653</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemos J, Eggenberger E (2013) Saccadic intrusions: review and update. Curr Opin Neurol 26:59–66. https://doi.org/10.1097/WCO.0b013e32835c5e1d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32835c5e1d</ArticleId><ArticleId IdType="pubmed">23302805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, Mu J, Guo J, Li W, Wang G (2020) New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. https://doi.org/10.1111/epi.16524</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16524</ArticleId><ArticleId IdType="pubmed">33236791</ArticleId><ArticleId IdType="pmcid">7264627</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. https://doi.org/10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pubmed">33324968</ArticleId><ArticleId IdType="pmcid">7799186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D, Santos-Fernández T, Folgueira-López MD, Gutiérrez-Gutiérrez J, Ayuso-García B (2020) Generalized myoclonus in COVID-19. Neurol. https://doi.org/10.1212/WNL.0000000000009829</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros-Castelló V, Quereda C, López-Sendón J, Corral I (2020) Post-hypoxic myoclonus after COVID-19 infection recovery. Mov Disord Clin Pract. https://doi.org/10.1002/mdc3.13025</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13025</ArticleId><ArticleId IdType="pubmed">32837961</ArticleId><ArticleId IdType="pmcid">7404875</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NW, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(20)30287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pubmed">33069310</ArticleId><ArticleId IdType="pmcid">7561324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323:1239–1242. https://doi.org/10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId><ArticleId IdType="pmcid">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B (2020) COVID-19: review of a 21st century pandemic from etiology to neuro-psychiatric implications. J Alzheimer’s Dis 77:459–504. https://doi.org/10.3233/JAD-200831</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200831</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000441 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000441 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:33492608
|texte= Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33492608" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |